all the information, none of the junk | biotech • healthcare • life sciences

Marathon and Zafgen Add to Series B Rounds, Athenahealth and Sermo Announce Partnership, Sensata Sets IPO Terms, & More Boston-Area Deals News

(Page 2 of 2)

tapping into Cambridge-based Sermo’s community for their perspectives on electronic health records.

—IPO news continued this week with Sensata Technologies, an Attleboro, MA maker of sensors and switches. The Bain Capital-owned company set its initial public offering of 31.6 million common shares at $18 to $20 a share.

—German pharmaceuticals giant Merck KGaA (not to be confused with the U.S Merck & Co.) will acquire all outstanding shares of life sciences equipment supplier Millipore at $107 a share, Millipore (NYSE: MIL) announced. News of the all-cash, $7.2 billion transaction came as a bit of a surprise; previous reports stated Thermo Fisher had made a $6 billion bid for Billerica, MA-based Millipore.

Cambridge’s Zafgen added $8.1 million to its Series B round, bringing the amount collected for the round to date to $28 million, a company spokeswoman said. The company, which focuses on treatments for obesity, raised the funding from existing investors Third Rock Ventures in Boston and Atlas Venture in Waltham, MA.

TransMedics, which develops systems for transporting organs for transplant, raised $35.4 million, showed an SEC filing. The equity round for the Andover, MA-based company included about $9 million from convertible debt.

Japan-based Konica Minolta will pump $20 million through R&D and investments into Konarka Technologies, a developer of nanotechnology-based products that convert light to energy, the Lowell, MA-based company announced today. They’re planning to develop thin-film photovoltaic panels together.

Single PageCurrently on Page: 1 2 previous page